RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
This agreement expands RadioMedix's access to essential 228Th resources, strengthening the Company's 212Pb pipeline and generator platform for its long-term Targeted Alpha Therapy strategy HOUSTON, Dec. 12, 2025 (GLOBE NEWSWIRE) — RadioMedix, Inc., a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and cancer therapy, today announced that they have entered into […]